| Patents for C07H 19 - Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro derivatives thereof (20,008) |
|---|
| 03/20/2013 | CN102977169A Preparation method of 2'3'-di-O-acetyl-5'-desoxy-5-fluoro-N4-(pentyloxycarbonyl)cytidine |
| 03/19/2013 | US8399196 Nucleic acid sequencing methods, kits and reagents |
| 03/14/2013 | WO2013036868A1 Synthesis and uses of nucleic acid compounds with conformationally restricted monomers |
| 03/14/2013 | WO2013036846A2 N4 derivatives of deoxycytidine prodrugs |
| 03/14/2013 | US20130066063 Bicyclo[6.1.0]non-4-yne regents for chemical modification of oligonucleotides |
| 03/14/2013 | US20130064794 Substituted Carbonyloxymethylphosphoramidate Compounds and Pharmaceutical Compositions for the Treatment of Viral Infections |
| 03/14/2013 | US20130064793 Compounds and pharmaceutical compositions for the treatment of viral infections |
| 03/13/2013 | EP2567964A2 Monomer Compositions for the Synthesis of RNA, Methods of Synthesis, and Methods of Deprotection |
| 03/13/2013 | EP2566966A1 Treatment of sirtuin (sirt) related diseases by inhibition of natural antisense transcript to a sirtuin (sirt) |
| 03/13/2013 | CN102971335A Reagents for reversibly terminating primer extension |
| 03/13/2013 | CN101787065B Cytarabine prodrug derivatives and purposes thereof in resisting cancers and tumors |
| 03/13/2013 | CN101787064B Cytarabine derivatives and purposes thereof in resisting cancers and tumors |
| 03/12/2013 | US8394950 Analogues of coformycin and their use for treating protozoan parasite infections |
| 03/12/2013 | US8394949 Multisignal labeling reagents, and processes and uses therefor |
| 03/12/2013 | US8394934 Method and process for synthesis of 2',3'-didehydro-2',3'-dideoxynucleosides |
| 03/12/2013 | US8394586 Labelled nucleotides |
| 03/12/2013 | US8394584 Detecting and sorting methylated DNA using a synthetic nanopore |
| 03/07/2013 | WO2013033705A2 Non-natural nucleosides as theranostic agents |
| 03/07/2013 | US20130059810 Pharmaceutical compositions comprising forms of 5-azacytidine |
| 03/07/2013 | US20130059809 Pharmaceutical compositions comprising forms of 5-azacytidine |
| 03/07/2013 | US20130059384 Compositions and methods for enhancing bioenergetic status in female germ cells |
| 03/07/2013 | US20130059343 Nucleotide derivatives |
| 03/07/2013 | US20130058866 N-pyrazole a2a receptor agonists |
| 03/06/2013 | EP2563801A2 Substitution derivatives of n6-benzyladenosine-5´-monophosphate, methods of preparation thereof, use thereof as medicaments, and therapeutic preparation containing these compounds |
| 03/06/2013 | CN102952167A Method for dilution crystallizationelution and crystallization of cytidine 5'-disodium phosphate |
| 03/05/2013 | US8389703 Ribonucleoside analogs with novel hydrogen bonding patterns |
| 03/05/2013 | US8389702 Multi-oligomeric or multi-polymeric compositions comprising labeled moieties and binding partners |
| 03/05/2013 | US8389701 Multisignaling oligomeric or polymeric compositions comprising labeled moieties and binding partners |
| 02/28/2013 | WO2013027843A1 Glucoside compound, method for producing thioether, ether, method for producing ether, method for producing glucoside compound, method for producing nucleic acid |
| 02/28/2013 | WO2013026424A1 A method for the preparation of 2-[4-[(methylamino) carbonyl] -1-h-pyrazol-1-yl] adenosine monohydrate |
| 02/28/2013 | WO2013026142A1 Ionic tags for synthesis of oligoribonucleotides |
| 02/28/2013 | WO2012166705A3 Supramolecular nanofibers and hydrogels based on amino acid-nucleobase-glycoside conjugates |
| 02/28/2013 | WO2012158811A3 Purine monophosphate prodrugs for treatment of viral infections |
| 02/28/2013 | US20130055417 Hormone responsive tissue culture system and uses thereof |
| 02/28/2013 | US20130053338 Use of P2X Purinergic Receptor Agonists to Enhance Insulin Secretion in Pancreatic Beta Cells |
| 02/28/2013 | US20130053252 Nucleic acid amplification and sequencing by synthesis with fluorogenic nucleotides |
| 02/28/2013 | US20130052710 Rna including nucleoside compound, method for regulating amount of protein produced from the rna, and nucleoside compound |
| 02/28/2013 | US20130052690 Pcr primer and method for reducing non-specific nucleic acid amplification using a photolabile protecting group |
| 02/28/2013 | US20130052160 Compounds and uses thereof to induce an immunogenic cancer cell death in a subject |
| 02/28/2013 | CA2846572A1 Glycoside compound, method for producing thioether, ether, method for producing ether, method for producing glycoside compound, method for producing nucleic acid |
| 02/27/2013 | EP2562255A1 Nucleic acid base analog with quenching characteristics and fluorescence and application thereof |
| 02/27/2013 | EP2560982A2 Phosphoramidites for synthetic rna in the reverse direction |
| 02/27/2013 | CN202754925U Deoxyadenosine series product large-scale production device |
| 02/26/2013 | US8383795 Detection and quantification of biomolecules using mass spectrometry |
| 02/26/2013 | CA2358570C Protonated/acidified nucleic acids and methods of use |
| 02/21/2013 | WO2013023626A1 A method for the preparation of 2-(4-methoxycarbonylpyrazol-l-yl)adenosine and 2-(4-ethoxycarbonylpyrazol-l-yl)adenosine |
| 02/21/2013 | US20130045950 Phosphonate Compounds |
| 02/21/2013 | US20130045949 Anti-cancer agents |
| 02/21/2013 | US20130045942 N6-substituted adenosine derivatives and n6-substituted adenine derivatives and uses thereof |
| 02/21/2013 | US20130045475 2-Nitrobenzyl-Modified Ribonucleotides |
| 02/20/2013 | EP2558586A1 APTAMERS TO ß-NGF AND THEIR USE IN TREATING ß-NGF MEDIATED DISEASES AND DISORDERS |
| 02/20/2013 | EP2558478A1 5-position modified pyrimidines and their use |
| 02/20/2013 | CN102936271A Method for extracting cordycepin |
| 02/19/2013 | US8377905 Stable crystal of 1-(2′-cyano-2′-deoxy-β-D-arabinofuranosyl)cytosine monohydrochloride |
| 02/19/2013 | US8377644 2′-arabino-fluorooligonucleotide N3′→P5′ phosphoramidates: their synthesis and use |
| 02/19/2013 | CA2447240C Method for the synthesis of dna sequences |
| 02/14/2013 | US20130041144 5'-substituted bicyclic nucleosides and oligomeric compounds prepared therefrom |
| 02/14/2013 | US20130041104 Conjugates of 18f carriers having bioactive, organic compounds and the preparation thereof |
| 02/14/2013 | US20130041011 Base modified bicyclic nucleosides and oligomeric compounds prepared therefrom |
| 02/14/2013 | US20130040908 Substitution derivatives of n6-benzyladenosine-5' -monophosphate, methods of preparation thereof, use thereof as medicaments, and therapeutic preparations containing these compounds |
| 02/14/2013 | US20130040907 Compounds, Compositions and Methods of Using Same for Modulating Uric Acid Levels |
| 02/13/2013 | EP2556081A2 A cytosine analogue, a method of preparation of a cytosine analogue, a dna methyltransferase 1 inhibitor, a method for dna methylation inhibition, the use of the analogue in the treatment of diseases associated with deviations from normal dna methylation |
| 02/13/2013 | CN102933593A Method of reducing intraocular pressure in humans using n6-cyclopentyladenosine (cpa), cpa derivatives or prodrugs thereof |
| 02/13/2013 | CN102933570A Method for producing (2r)-2-fluoro-2-c-methyl-d-ribono-y-lactone precursor |
| 02/13/2013 | CN102924552A Compound with anti-herpes-virus function |
| 02/13/2013 | CN102924551A Method for extracting vernine from fermentation liquor |
| 02/13/2013 | CN102924550A Decitabine 5'-O-amino-acid ester prodrug and preparation method thereof |
| 02/13/2013 | CN102924549A Modified 4'-nucleosides as antiviral agents |
| 02/13/2013 | CN102924548A Synthesis method of capecitabine |
| 02/13/2013 | CN101220069B Method for synthesizing deoxyadenosine compounds |
| 02/07/2013 | WO2012142093A3 2'-cyano substituted nucleoside derivatives and methods of use thereof for the treatment of viral diseases |
| 02/07/2013 | US20130035306 Process for preparing purine nucleosides |
| 02/07/2013 | US20130035237 Nucleotides and Nucleosides and Methods for their Use in DNA Sequencing |
| 02/07/2013 | US20130034598 Inhibitors of akt/pkb with anti-tumor activity |
| 02/06/2013 | EP2552933A1 Purine nucleoside phosphoramidate |
| 02/06/2013 | EP2552932A1 Adenosine compounds and their use thereof |
| 02/06/2013 | EP2552931A2 Stereoselective synthesis of phosphorus containing actives |
| 02/06/2013 | EP2552930A2 Nucleoside phosphoramidates |
| 02/06/2013 | EP2552203A1 Compounds and pharmaceutical compositions for the treatment of viral infections |
| 02/06/2013 | CN102918052A Ribonucleoside phosphorothioate manufacturing method |
| 02/06/2013 | CN102911230A Synthesis method of fludarabine |
| 02/06/2013 | CN102911229A 1-Beta-D-ribofuranosyl cytosine preparation method |
| 02/06/2013 | CN101827856B 2 ' -fluoro-2 ' -deoxytetrahydrouridines as cytidine deaminase inhibitors |
| 02/06/2013 | CN101233144B 稳定的nad/nadh衍生物 Stable nad / nadh derivatives |
| 02/05/2013 | US8367341 Method for detection of genetically modified maize BT11 |
| 02/05/2013 | CA2714085C Method of manufacture of 1,3-oxathiolane nucleosides |
| 01/31/2013 | WO2013013404A1 Water soluble camptothecin derivative, pharmaceutical composition and use thereof |
| 01/31/2013 | US20130029929 Nucleoside phosphoramidate prodrugs |
| 01/30/2013 | EP2551273A1 Phosphorylation reagent |
| 01/30/2013 | EP2550287A1 Methods and compositions comprising nucleic acid polymerization enhancers |
| 01/30/2013 | CN102906102A Stereoselective synthesis of phosphorus containing actives |
| 01/30/2013 | CN102898489A Rebeccamycin analogue with anticancer activity and synthetic method thereof |
| 01/29/2013 | US8361988 Nucleoside and nucleotide analogues with quaternary carbon centers and methods of use |
| 01/29/2013 | US8361727 3′OH-unblocked, nucleotides and nucleosides base modified with labels and photocleavable, terminating groups and methods for their use in DNA sequencing |
| 01/24/2013 | WO2013013009A2 2',3'-DIDEOXY-2'-α-FLUORO-2'-β-C-METHYLNUCLEOSIDES AND PRODRUGS THEREOF |
| 01/24/2013 | WO2013010573A1 Compounds with matrix-metalloproteinase inhibitory activity |
| 01/24/2013 | WO2012158552A3 2'-fluoro-6'-methylene carbocyclic nuceosides and methods of treating viral infections |
| 01/24/2013 | CA2842358A1 Methods for the synthesis of functionalized nucleic acids |
| 01/24/2013 | CA2842103A1 Embodiments of a probe and method for targeting nucleic acids |
| 01/23/2013 | CN101709073B Nucleotide phospholipid molecule and lipidosome and preparation method and application thereof |